{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:13:41Z","timestamp":1778840021807,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005632","name":"National Centre for Research and Development","doi-asserted-by":"publisher","award":["ERA-NET-E-RARE-3\/III\/TreatPolyQ\/08\/2018"],"award-info":[{"award-number":["ERA-NET-E-RARE-3\/III\/TreatPolyQ\/08\/2018"]}],"id":[{"id":"10.13039\/501100005632","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002243","name":"National Ataxia Foundation","doi-asserted-by":"publisher","award":["688790"],"award-info":[{"award-number":["688790"]}],"id":[{"id":"10.13039\/100002243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004382","name":"Polska Akademia Nauk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","award":["ANR-17-RAR3-0008-04_ACT"],"award-info":[{"award-number":["ANR-17-RAR3-0008-04_ACT"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004569","name":"Ministerstwo Edukacji i Nauki","doi-asserted-by":"publisher","award":["DIR\/WK\/2018\/06"],"award-info":[{"award-number":["DIR\/WK\/2018\/06"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.omtn.2025.102496","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T11:32:33Z","timestamp":1740223953000},"page":"102496","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["CAG-targeted brain-permeable therapy tested in biallelic humanized polyQ mouse models"],"prefix":"10.1016","volume":"36","author":[{"given":"Magdalena","family":"Surdyka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u017baneta","family":"Kalinowska-Po\u015bka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Niewiadomska-Cimicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewelina","family":"Jesion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Fiszer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Singer-Mikosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorraine","family":"Fievet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukasz","family":"Przybyl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas S.","family":"Caron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huu Phuc","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvon","family":"Trottier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3961-4635","authenticated-orcid":false,"given":"Maciej","family":"Figiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2025.102496_bib1","series-title":"Advances in Genetics","first-page":"293","article-title":"Chapter Seven - Application of yeast to studying amyloid and prion diseases","author":"Chernoff","year":"2020"},{"key":"10.1016\/j.omtn.2025.102496_bib2","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3389\/fnins.2020.00571","article-title":"Gene Deregulation and Underlying Mechanisms in Spinocerebellar Ataxias With Polyglutamine Expansion","volume":"14","author":"Niewiadomska-Cimicka","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.omtn.2025.102496_bib3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.conb.2021.07.001","article-title":"Polyglutamine diseases","volume":"72","author":"Bunting","year":"2022","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.omtn.2025.102496_bib4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington\u2019s disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.omtn.2025.102496_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.621996","article-title":"Protein Aggregation Inhibitors as Disease-Modifying Therapies for Polyglutamine Diseases","volume":"15","author":"Minakawa","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.omtn.2025.102496_bib6","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3727\/096368914X678454","article-title":"Polyglutamine (PolyQ) diseases: genetics to treatments","volume":"23","author":"Fan","year":"2014","journal-title":"Cell Transplant."},{"key":"10.1016\/j.omtn.2025.102496_bib7","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","author":"Macdonald","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2025.102496_bib8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ng1194-221","article-title":"CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1","volume":"8","author":"Kawaguchi","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2025.102496_bib9","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.drudis.2012.01.006","article-title":"Allele-selective inhibition of trinucleotide repeat genes","volume":"17","author":"Matsui","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.omtn.2025.102496_bib10","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00018-020-03596-7","article-title":"Artificial miRNAs targeting CAG repeat expansion in ORFs cause rapid deadenylation and translation inhibition of mutant transcripts","volume":"78","author":"Ciesiolka","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.omtn.2025.102496_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-78521-w","article-title":"A comparison of AAV-vector production methods for gene therapy and preclinical assessment","volume":"10","author":"Davidsson","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2025.102496_bib12","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3390\/biology12020186","article-title":"AAV Engineering for Improving Tropism to the Central Nervous System","volume":"12","author":"Ghauri","year":"2023","journal-title":"Biology"},{"key":"10.1016\/j.omtn.2025.102496_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.00082","article-title":"Cortical and Striatal Circuits in Huntington\u2019s Disease","volume":"14","author":"Blumenstock","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.omtn.2025.102496_bib14","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00018-022-04280-8","article-title":"Modifier pathways in polyglutamine (PolyQ) diseases: from genetic screens to drug targets","volume":"79","author":"Costa","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.omtn.2025.102496_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-019-0074-3","article-title":"Spinocerebellar ataxia","volume":"5","author":"Klockgether","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.omtn.2025.102496_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104635","article-title":"Pathogenesis of SCA3 and implications for other polyglutamine diseases","volume":"134","author":"McLoughlin","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.omtn.2025.102496_bib17","first-page":"1115","article-title":"A novel humanized mouse model of Huntington disease for preclinical development of therapeutics targeting mutant huntingtin alleles","volume":"26","author":"Southwell","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2025.102496_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1122308","article-title":"Impaired interactions of ataxin-3 with protein complexes reveals their specific structure and functions in SCA3 Ki150 model","volume":"16","author":"Piasecki","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.omtn.2025.102496_bib19","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.chembiol.2010.10.013","article-title":"Allele-Selective Inhibition of Huntingtin Expression by Switching to an miRNA-like RNAi Mechanism","volume":"17","author":"Hu","year":"2010","journal-title":"Chem. Biol."},{"key":"10.1016\/j.omtn.2025.102496_bib20","doi-asserted-by":"crossref","first-page":"9329","DOI":"10.1021\/bi4014209","article-title":"Allele-Selective Inhibition of Expression of Huntingtin and Ataxin-3 by RNA Duplexes Containing Unlocked Nucleic Acid Substitutions","volume":"52","author":"Aiba","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.omtn.2025.102496_bib21","doi-asserted-by":"crossref","first-page":"10426","DOI":"10.1093\/nar\/gkt825","article-title":"Self-duplexing CUG repeats selectively inhibit mutant huntingtin expression","volume":"41","author":"Fiszer","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2025.102496_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/genes7120132","article-title":"Mutant CAG Repeats Effectively Targeted by RNA Interference in SCA7 Cells","volume":"7","author":"Fiszer","year":"2016","journal-title":"Genes"},{"key":"10.1016\/j.omtn.2025.102496_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.658339","article-title":"Broad Influence of Mutant Ataxin-3 on the Proteome of the Adult Brain, Young Neurons, and Axons Reveals Central Molecular Processes and Biomarkers in SCA3\/MJD Using Knock-In Mouse Model","volume":"14","author":"Wiatr","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.omtn.2025.102496_bib24","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/mt.2009.246","article-title":"Systematic Evaluation of AAV Vectors for Liver directed Gene Transfer in Murine Models","volume":"18","author":"Wang","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102496_bib25","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.3390\/pharmaceutics13071018","article-title":"New Perspectives of Gene Therapy on Polyglutamine Spinocerebellar Ataxias: From Molecular Targets to Novel Nanovectors","volume":"13","author":"Borbolla-Jim\u00e9nez","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.omtn.2025.102496_bib26","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/nn.4593","article-title":"Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems","volume":"20","author":"Chan","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.omtn.2025.102496_bib27","doi-asserted-by":"crossref","first-page":"5534","DOI":"10.1523\/JNEUROSCI.2074-20.2021","article-title":"Single-Nucleus RNA-Seq Reveals Dysregulation of Striatal Cell Identity Due to Huntington\u2019s Disease Mutations","volume":"41","author":"Malaiya","year":"2021","journal-title":"J. Neurosci."},{"key":"10.1016\/j.omtn.2025.102496_bib45","series-title":"Modified cmv promoters that are resistant to gene silencing","author":"Yang","year":"2015"},{"key":"10.1016\/j.omtn.2025.102496_bib28","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.omtm.2020.10.011","article-title":"CNS Transduction Benefits of AAV-PHP.eB over AAV9 Are Dependent on Administration Route and Mouse Strain","volume":"19","author":"Mathiesen","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2025.102496_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcab105","article-title":"Use of high-content imaging to quantify transduction of AAV-PHP viruses in the brain following systemic delivery","volume":"3","author":"Smith","year":"2021","journal-title":"Brain Commun."},{"key":"10.1016\/j.omtn.2025.102496_bib30","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.1073\/pnas.0801775105","article-title":"Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: Implications for the therapeutic development of RNAi","volume":"105","author":"McBride","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2025.102496_bib31","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/jnnp.2003.017822","article-title":"Rate and correlates of weight change in Huntington\u2019s disease","volume":"75","author":"Hamilton","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.omtn.2025.102496_bib32","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1093\/hmg\/ddl072","article-title":"Body weight is modulated by levels of full-length huntingtin","volume":"15","author":"Van Raamsdonk","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2025.102496_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101439","article-title":"Hypothalamic expression of huntingtin causes distinct metabolic changes in Huntington\u2019s disease mice","volume":"57","author":"Dickson","year":"2022","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.omtn.2025.102496_bib34","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1093\/brain\/awac458","article-title":"AAV5-miHTT-mediated huntingtin lowering improves brain health in a Huntington\u2019s disease mouse model","volume":"146","author":"Thomson","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.omtn.2025.102496_bib35","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1093\/hmg\/ddg352","article-title":"Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis","volume":"12","author":"Kennedy","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2025.102496_bib36","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.ymthe.2023.05.006","article-title":"Di-valent siRNA-mediated silencing of MSH3 blocks somatic repeat expansion in mouse models of Huntington\u2019s disease","volume":"31","author":"O\u2019Reilly","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102496_bib37","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S1474-4422(20)30343-4","article-title":"Interrupting sequence variants and age of onset in Huntington\u2019s disease: clinical implications and emerging therapies","volume":"19","author":"Wright","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.omtn.2025.102496_bib38","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.ajhg.2019.04.007","article-title":"Length of Uninterrupted CAG, Independent of Polyglutamine Size, Results in Increased Somatic Instability, Hastening Onset of Huntington Disease","volume":"104","author":"Wright","year":"2019","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2025.102496_bib39","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.3390\/ijms25084354","article-title":"AAV-Mediated CAG-Targeting Selectively Reduces Polyglutamine-Expanded Protein and Attenuates Disease Phenotypes in a Spinocerebellar Ataxia Mouse Model","volume":"25","author":"Niewiadomska-Cimicka","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2025.102496_bib40","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.omtn.2019.12.012","article-title":"Universal RNAi Triggers for the Specific Inhibition of Mutant Huntingtin, Atrophin-1, Ataxin-3, and Ataxin-7 Expression","volume":"19","author":"Kotowska-Zimmer","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2025.102496_bib41","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.omtn.2022.04.031","article-title":"A CAG repeat-targeting artificial miRNA lowers the mutant huntingtin level in the YAC128 model of Huntington\u2019s disease","volume":"28","author":"Kotowska-Zimmer","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2025.102496_bib42","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1093\/nar\/gkr156","article-title":"Inhibition of mutant huntingtin expression by RNA duplex targeting expanded CAG repeats","volume":"39","author":"Fiszer","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2025.102496_bib43","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.nbd.2014.09.020","article-title":"A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3\/MJD","volume":"73","author":"Switonski","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.omtn.2025.102496_bib44","first-page":"e1787","article-title":"A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia","author":"Guyenet","year":"2010","journal-title":"JoVE J."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253125000502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253125000502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T09:56:40Z","timestamp":1778839000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253125000502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2162253125000502"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2025.102496","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CAG-targeted brain-permeable therapy tested in biallelic humanized polyQ mouse models","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2025.102496","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102496"}}